Pfizer/BioNTech Covid vaccine confirmed to protect 95% in largest study yet

The largest real-world study yet of the Pfizer/BioNTech vaccine has confirmed that the jab provided more than 95 percent protection against Covid-19.

The largest real-world study yet of the Pfizer/BioNTech vaccine on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses. The authors of the research from Israel's national vaccination campaign said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes. An analysis of public health data from Israel -- one of the countries with the highest proportion of fully-vaccinated adults -- showed the vaccine was extremely effective in protecting even elderly individuals at a time when the more infectious English variant was dominant, according to the results published in the Lancet medical journal.